XML 53 R41.htm IDEA: XBRL DOCUMENT v3.25.3
Summary of Non-Qualified Stock Options (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised   (200,000)      
Stock Appreciation Rights (SARs) [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 58.93   $ 58.93   $ 58.90
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price     0    
Weighted Average Exercise Price, Exercises in Period (in dollars per share)     58.86    
Weighted Average Exercise Price, Forfeitures in Period (in dollars per share)     0    
Weighted Average Exercise Price, Exercisable (in dollars per share) $ 58.93   $ 58.93    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value     $ 43.3    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 428,393   428,393    
Weighted Average Remaining Contractual Term, Exercisable (in years)     3 years 9 months 18 days    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $ 65.4   $ 65.4    
Share-based Payment Arrangement, Option          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross 0 0 89,221 85,425  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised     (14,256)    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures     (19,805)    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 156.14   $ 156.14   $ 147.08
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price     180.72    
Weighted Average Exercise Price, Exercises in Period (in dollars per share)     141.78    
Weighted Average Exercise Price, Forfeitures in Period (in dollars per share)     169.76    
Weighted Average Exercise Price, Exercisable (in dollars per share) $ 142.30   $ 142.30    
Weighted Average Remaining Contractual Term, Outstanding (in years)     7 years 8 months 12 days    
Aggregate Intrinsic Value, Outstanding $ 16.1   $ 16.1    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value     $ 0.9    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number 289,974   289,974   234,814
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 144,986   144,986    
Weighted Average Remaining Contractual Term, Exercisable (in years)     6 years 6 months    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $ 10.0   $ 10.0